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Summary: A method is described by which the concentration of deoxyhaemoglobin, oxyhaemoglobin, carboxy-
haemoglobin, haemigjobin and sulphaemoglobin in a human blood sample is determined by passing the haemolysate
without air contact through a coarse filter and subsequently measuring the absorbance at = 500, 569, 577, 620 and
760 nm. The euouing set of equations is solved by matrix calculation with the aid of a simple computer program. The
method has been tested by comparing it with conventional methods for the determination of the various haemoglobin
derivatives separately.
Eine Viel-Wellenlängen Methode für die simultane spektrophotometrische Bestimmung
von fünf Hämoglobinderivaten
Zusammenfassung: Eine Methode, mit der die Konzentration von Desoxyhämoglobin, Oxyhämoglobin, Carboxy-
hämoglobin, Hämiglobin und Sulfhämogjobin in einer Blutprobe vom Menschen bestimmt werden kann, wird beschrie-
ben. Das Hämolysat durchläuft ohne Luftkontakt ein grobes Filter; die Absorption bei = 500, 569, 577, 620 und
760 nm wird gemessen. Der sich ergebende Satz von Gleichungen wird durch Matrizen-Berechnung mit Hilfe eines
einfachen Rechnerprogramms gelöst. Die Methode wurde durch Vergleich mit konventionellen Methoden für die
separate Bestimmung der verschiedenen Hämoglobinderivate geprüft.
Introduction
Numerous Spectrophotometric methods have been
devised for the determination of haemoglobin and its
common derivatives (1). Most of these are two^wave-
length methods for the analysis of two-component sys-
tems. By proper preparation of the samples and/or by
judicious wavelength selection, care is taken that no
more than two haemoglobin derivatives determine the
absorption at the two wavelengths. In most of these
methods one wavelength is chosen at a cross-over point
in the absorption spectra of the two components
(isosbestic wavelength), which results in a linear relation-
ship between the ratio of the absorptions measured at
the two wavelengths and the relative concentration of
each of the components. The importance of this advan-
tage, however, has diminished since simple and inexpen-
sive calculators came into general use. So there is now
little ground for adhering to the use of an isosbestic
wavelength. In fact, in some cases it is even desirable
not to use it.
This is, for instance, the case in measuring the oxygen
saturation of blood independent of the possible presence
of indocyanine green, a dye commonly used for the
determination of cardiac output. The absorption maxi-
mum of indocyanine green almost coincides with the
isosbestic point of deoxyhaemoglobin (Hb) and oxy-
haemoglobin (HbO?) at = 800 nm (fig. 1). Therefore,
= 860 nm is used instead, thus eliminating the influ-
ence of the dye on the oxygen saturation measurement
(2).
Until recently, the analysis of blood samples containing
more than two haemoglobin derivatives has been much
more difficult. Nevertheless, various methods have been
developed, especially for the simultaneous determina-
tion of carboxyhaemoglobin (HbCO) and haemiglobin
(methaemoglobin; Hi) (3, 4, 5), or HbCO, Hi and sulph-
haemoglobin (SHb) (6). All these methods are rather
cumbersome. They involve elaborate preparatory meas-
ures and the determination of correction factors or the
use of special nomograms. Extensive manipulation of
the blood samples is especially undesirable when Hb and
HbO2 have to be measured in addition to one or more
dyshaemoglobins (HbCO, Hi, SHb) (7), as any contact
with air may cause a change in oxygenation.
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Fig. I.Absorption spectra of Hb ( ), Hb02 ( ), HbCO (-·-), Hi(-—) (pH 7.0-7.4) and SHb (-—).·
Since the lineic absorbances1) of most common haemo-
globin derivatives are known over a wide spectral range
(8,9), it would seem astonishing that no straightforward
multi-wavelength methods have been developed for the
simultaneous determination of oxygen saturation, one
or more dyshaemoglobins and total haemoglobin in
human blood. The introduction of such methods, how-
ever, has for years been impeded by the fact that no
practical method was available for removing all scattering
particles from the haemolysate so that the lineic absorb-
ances determined with partly purified haemoglobin
solutions could be applied. Most filtering procedures
appeared to need high pressures, and they resulted in a
clogged filter before enough filtrate was obtained.
Moreover, it was necessary to avoid any contact between
sample and ambient air, or any appreciable degree of
dilution of the sample, as these may cause changes in
oxygenation. The application in the clinical chemical
laboratory of a multi-wavelength method for the deter-
mination of haemoglobin derivatives has until recently
also been impeded by the lack of a simple means of
solving a set of equations with more than three un-
knowns. Since the absorption spectrum of SHb was not
accurately known, it was also impossible to include all
clinically important haemoglobin derivatives in the assay.
Easy processing of Spectrophotometric data was made
possible for the clinical chemist by the advent of micro-
computers and programmable calculators. The necessary
data on the absorption spectrum of SHb is available
from recent work in our laboratory (7). As a solution
to the main problem, it was found that filtration through
a rather coarse filter, e.g. a piece of cotton wool, removes
enough scattering material from the haemolysate so that
the use of the known lineic absorbances of the common
haemoglobin derivatives is valid. This paper describes
a five-wavelength method for the simultaneous deter-
mination of Hb, Hb02, HbCO, Hi and SHb. The sum
of the concentrations of the five haemoglobin derivatives
proved to be equal to the total haemoglobin concentra-
J) Lineic absorption is the new, IUPAC/IFCC approved term
for exctinction coefficient.
tion (cSb) as determined with the internationally stand-
ardized haemiglobin cyanide (HiCN) method (10,11).
Application of both methods to the same blood sample
thus affords an opportunity for interparametric quality
control (12).
Methods
If a solution contains n dissolved substances with considerable
differences between their absorption spectra, this n-component
system can be analysed by measuring at at least n different wave-
lengths. These measurements provide n equations of the type
A = •I (Eq.l)
where Áë = absorbance (log/0/7) at wavelength \, en = lineic
absorbance of component ç at wavelength K, cn = concentration
of component n, and / = lightpath length. The values of c\,
€2 cn can be calculated by solving the set of equations,
assuming that the values of e^ and / are known.
For the simultaneous determination of Hb, HbC2, HbCO, Hi
and SHb in human blood the absorbance of the haemolysate
must be measured at 5 wavelengths. These wavelengths have
been chosen in such a way that for each a (local) maximum is
used: ë = 760 nm for Hb, ë = 577 nm for Hb02, ë = 569 nm
for HbCO, ë = 500 nm for Hi and ë = 620 nm for SHb. Table 1
shows the 5-5 matrix of millimolar lineic absorbances. Most of
these values have been taken from Van Assendelft (8), while
*SHb at ë = 500,569,577 and 620 nm are taken from Dijkhuizen
et al. (7). In the course of this investigation €§5^0 an<* cSHb
were redetermined.
The two haemoglobin derivatives that usually account for the
largest part of the mixture (Hb and Hb02) have very different
lineic absorbances at ë = 500, 569 and 577 nm on the one hand
and ë = 620 and 760 nm on the other. Therefore, it proved
Tab. 1. Matrix of millimolar lineic absorbances e expressed in
OTf1· minor1 -1=10*
\(nm)
500
569
577 '
620
760
Hb
4.09
11.27
9.40
1.23
0.43
HbO2
5.05
11.27
15.37
0.24
0.13
• m2 · mol"1
HbCO
5.35
14.27
10.00
0.33
0.03
(cf. fig. 1).
Hi
9.04
4.10
4.10
3.35
0.24
SHb
7.20
8.10
8.10
20.80
1.04
/ (ë = 500, 569,577) < 0.01 cm exactly calibrated
/(ë = 620, 760) -0.2 cm to4 decimaLplaces
Italics indicate the chosen maximum of each derivative
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necessary to use two different pathlcngths to keep the absorb-
ance values within the range in which they can be measured with
reasonable accuracy (1, 8). At ë = 620 nm and 760 nm,
/ = 0.200 cm is adequate, whereas at ë = 500, 569 and 577 nm
it is necessary to keep / < 0.010 cm. In this investigation we
actually used / = 0.007 cm, achieved by inserting a 0.093 cm
plan-parallel glass plate (Hellma Benelux, The Hague, The Nether-
lands) into a 0.100 cm cuvette (fig. 2). The values of/ were
checked by measuring the absorbance at ë = 540 nm of HiCN
solutions of known concentration (13).
Fig. 2. Filling a 0.100 cm cuvette and inserting a 0.093 cm plan^
parallel glass plate. Cuvettes and glass inserts are stored in
a chromic acid solution, rinsed before use with demineral-
ized water followed by acetone and dried with an air jet.
The filter umt^between syringe and needle contains
cotton wool. The filter unit is cleaned, dried and filled
with new cotton wool before each determination.
A. Cuvette holder with reference cuvette, cuvette, glass
insert and 2 ml syringe with filter and needle, con-
taining the haemolyzed blood.
B. After discarding the first 10 drops the haemolysate is
gently pressed through the filter into the cuvette.
C. The plan-parallel glass plate is inserted into the cuvette,
leaving a lightpath length of 0.007 cm.
Procedures
Five-wavelength method
All measurements were made with freshly drawn, hcparinized
blood samples from apparently healthy humans of both sexes.
The sample was transferred without any contact with air to a
2 ml glass syringe containing a mixing ball (ö = 5 mm) and with
its dead space filled with a 5% solution of the non-ionic deter-
gent Sterox SE (Hartman-Leddon Comp., Philadelphia, Pa.,
USA). After thouroughly mixing blood and detergent solution,
a filter unit containing a piece of cotton wool was put on the
syringe. After discarding the first 10 drops to flush the needle
and filter space, the two cuvettes (/ = 0.200 and 0.100 cm) were
filled with the haemolysate, and the plan-parallel glass plate was
inserted into the 0.100 cm cuvette (fig. 2). The absorbances
were measured at ë = 500, 569, 577, 620 and 760 nm with an
Optica CF4 grating spcctrophotometer against similar cuvettes
filled with distilled water in the reference channel. The spectral
band width was less than 1 nm. The wavelength calibration was
checked with the aid of mercury emission lines and the absorb-
ance calibration with the aid of a carbon yellow filter (Corning
HT yellow 0-10; NBS test 178473 0-10). The concentrations of
the haemoglobin derivatives were calculated from the absorbance
values by matrix calculation using a desk top calculator
(HP9845 A; cf. Appendix). The slight differences between the
cuvettes in the measuring channel and the reference channel
and the dilution of the sample with Sterox SE solution were
taken into account. The concentrations of the various compo-
nents were calculated both in mmol · Ã1 and as a fraction of
total haemoglobin. In addition, the oxygen saturation
cHbO2 (Eq. 2)
was calculated, and the concentrations of the components were
added to obtain a value for Cfjb·
Preparation of blood samples
containing various haemoglobin derivatives
For testing the five-wavelength method, samples with different
amounts of the various haemoglobin derivatives were prepared.
As the conventional methods for measuring these derivatives,
except for the determination of Hi, are based on the assumption
that not more than two components are present, the test samples
were prepared accordingly. Blood with different ratios of Hb02
and Hb was prepared by tonometry with humidified 2/N2 mix-
tures containing 5.6% CO2 in a stainless steel chamber with a
magnetic stirrer at the bottom. The gases were fed into the tono-
meter through ports in.the perspex lid and the O2/N2 ratio was
adjusted by means of needle valves (14).
Blood with different ratios of HbCO and HbO2 was prepared in
the following way. A blood sample was divided into two parts.
One part was oxygenated by tonometry with humidified pure 2
for 30 min, yielding practically 100% HbO2- The other part was
subjected to tonometry with humidified pure CO for 15 min,
followed by 5% CO and 95% O2 for 15 min. This procedure
yields more than 90% HbCO, the remainder being HbO2-
Samples with different HbCO fractions were then made by mixing
various volumes from the two syringes in which the blood was
kept after tonometry.
To prepare blood samples with various amounts of Hi, blood was
haemolyzed by the addition of one drop of undiluted Sterox SE
and distributed to several test tubes to which various volumes of
a 90 mmol · Ã1 K3Fe(CN)e solution were added. The tubes
were kept for 90 min at room temperature before the samples
were measured.
Blood containing SHb was prepared according to Siggaard-An-
dersen et al. (6). First, the blood was fully oxygenated by
tonometry with humidified pure O2 for 2 h. One half of the
oxygenated blood was centrifuged and the packed cells incubated
for 30 min with an equal volume of a freshly prepared solution
of Na2S and HC1 (50 and 75 mmol · Ã1, respectively; pH « 7.5).
Next, excess H2S was removed by tonometry with humidified
pure O2 for 30 min and the blood, now containing 15-25%
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SHb, was stored in a gas-tight syringe. The other half of the
oxygenated blood was also stored in a syringe and samples with
different SHb content were prepared by mixing various volumes
from the two syringes.
Blood samples differing in total haemoglobin concentration were
prepared by separating erythrocytes and plasma from a certain
amount of blood and again mixing these components in different
ratios.
Conventional methods
When a two-component system is analysed by measuring at two
wavelengths, one of which is isosbestic for the two components,
it follows from the two equations of the type of Eq. 1 with
n = 2, that
cHi
(Eq.3)
where a and b are constants and ë2 is the isosbestic wavelength
(1). When the two components are Hb and HbO2, it follows
from Eqs. (2) and (3), that
(Eq.4)
ë1 ë2
a and b can be determined by measuring A /A for some fully
oxygenated (So2 = 1) and some completely deoxygenated
(S<32 = 0)blood samples. Suitable wavelengths for the deter-
mination of 5o2 are ë = 680 and 800 nm. At the isosbestic point
(ë = 800 nm) the absorption spectra of Hb and Hb02 are rather
flat (2) and ë = 680 nm is in the range of maximum spectral
sensitivity for the determination of SQ^ (15). Measurement of
blood from 6 humans and 8 dogs gave a = - 0.3819 and
b = 1.1633 (2). For each measurement 2 ml blood was trans-
ferred anaerobically to a 2 ml syringe containing a glass ball
(0 = 5 mm) for mixing and with its dead space filled with a 5 %
Sterox SE solution. After thoroughly mixing the sample and
discarding the first drops, the sample was injected into a plan-
parallel glass cuvette with / = 0.200 cm. A680 andX800 were
measured using an Optica CF4 grating spectrophotometer with
an effective band width < 1 nm. SQ was calculated with the
aid of Eq. 5 2
= 1.1633 -0.3819A
6
*°
A 800
(Eq.7)
where-4i,A2, A$ and A 4 represent the absorbances at
ë = 630 nm of the four blood reagent mixtures arid c
total haemoglobin concentration.
SHb was determined by means of the following procedure.
0.5 ml blood was added to 25 ml of a solution containing 0.05%
Sterpx SE and a phosphate buffer (27.50 mmol -1"1 Na2HPO4
and 13.16 mmol · Ã* KH2PO4; pH = 7.4). The absorbance of
this solution was measured at ë = 620 rim (Optica CF4) with
either / ^ 1.00 cm or / = 4.00 cm according to the absorbance
level. This one-wavelength method allows the calculation of the
SHb fraction only when an appropriate correction is made for
the absorbance of the other component present, i.e. Hb02 (Hi
was excluded in all samples measured). This correction has been
included in the equation for calculating SHb.
cSHb .620
620
(Eq. 5)
(Eq. 8)
where c' represents the total haemoglobin concentration of the
diluted blood in mmol · Ã1, and e|lib and €§^Q are the milli-
molar lineic absorbances of SHb and HbO2 at ë = 620 nm
(table 1).
The total haemoglobin concentration of the test samples was
determined as HiCN in conformity with the recommendations of
ICSH(ll).
Results
Figure 3 shows the results of 22 comparative determina-
tions of ·5¼2 with the five-wavelength method and the
680/800 method. The systematic differences of the five-
wavelength method with respect to the 680/800 method
was 1.2%So2 with a standard deviation of 23%SOi,
The results of 32 comparative measurements of the
HbCO fraction with the five-wavelength method and the
562/540 method are shown in figure 4. The systematic
difference of the five-wavelength method with respect to
For the determination of the HbCO fraction in the samples
containing HbCO and HbO2 a similar method was used. The
wavelengths selected for this determination were ë = 562 and
540 nm, the latter being isosbestic. The measurements were
carried out with / = 0.007 cm (fig. 2). The constants of Eq. 6
have been determined by calibration against a titrimetric method
for HbCO in blood (16).
cHbCO A 562
3.215^— -1.923.
^540 (Eq.6)
The Hi fraction in the test samples was determined with a KCN
addition method (1, 7,17). Four reagent solutions were used.
Solution 1 contained 0.05% Sterox SE and a phosphate buffer
(27.50 mmol · Ã1 Na2HPO4 and 13.16 mmol · Ã1 KH2PO4;
pH = 7.4). Solutions 2 and 3 contained in addition 3.84 mmol ·
Ã1 KCN and 3.04 mmol · Ã1 K3Fe(CN)6, respectively. Solu-
tion 4 contained in addition 3.84 mmol · Ã1 KCN as well as
3.04 mmol · Ã1 K3Fe(CN)6. 0.5 ml blood was added to 25 ml
of each of the four solutions. In the second solution all Hi
present becomes converted into HiCN. In the third and the fourth
solution all haemoglobin present is converted into Hi and HiCN,
respectively. The absorbance of the four solutions was measured
at ë = 630 nm (Optica CF4) with either / = 1.00 cm or / = 4.00 cm
according to the absorbance level. The Hi fraction was calculated
with the aid of Eq. 7.
100
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;£ 60
20
20 40 60
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Fig. 3. S02 (5 ë) plotted against SOt (680/800) for 22 blood
samples from 3 healthy humans. Regression equation:
$0, (5 ë) = 1.03 X So, (680/800) - 0.32.-Correlation
coefficient: 0.993;
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Fig. 4. HbCO (5 ë) plotted against HbCO (562/540) for 32 blood
samples from 7 healthy humans. Regression equation:
% HbCO (5 ë) = 0.99x % HbCO (562/540) + 1.45.
Correlation coefficient: 0.996.
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Fig. 6. SHb (5 ë) plotted against SHb (620) for 8 blood samples
from a healthy human. Regression equation: % SHb
(5 \) = 0.99÷ % SHb (620) - 0.52. Correlation coefficient:
0.998.
the 562/540 method was 1.2% HbCO with a standard
deviation of 1.7% HbCO. Figure 5 shows the results of
16 comparative measurements of the Hi fraction with
the five-wavelength method and the KCN addition
method. The systematic difference of the five-wavelength
method with respect to the KCN addition method was
- 0.4% Hi with a standard deviation of 0.7% Hi. Eight
comparative measurements of the SHb fraction with
the five-wavelength method and the 620 method are
shown in figure 6. The systematic difference of the five-
wavelength method with respect to the 620 method was
- 0.6% SHb with a standard deviation of 0.2% SHb.
Figure 7 shows the relationship between c^b as deter-
mined by adding the concentrations of all haemoglobin
derivatives present in the sample (five-wavelength
method) and cftb as determined by the HiCN method.
0 5 10 15 20 25 30
:Hi(CfT addition) [%]
Fig. 5. Hi (5 ë) plotted against Hi (KCN addition method) for
16 blood samples from 4 healthy humans. Regression
equation: % Hi (5 ë) = 0.99x »Hi (KCN) - 0.31. Correla-
tion coefficient: 0.994.
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Fig. 7. cfcb (5 ë) plotted against cftb (HiCN) for 22 blood
samples of 5 healthy humans. Regression equation:
cHb (5 ë) = 1-00 cj-ib (HiCN) - 0.07. Correlation coeffi-
cient: 0.988.
The systematic difference of the five-wavelength method
with respect to the HiCN method was - 0.06 g · dl"1 with
a standard deviation of 0.15 g - df1 (n = 22).
Discussion
This method for the simultaneous determination of
5 haemoglobin derivatives was developed following the
observation that by simple filtration through cotton
wool scattering particles can be removed from a haemoly-
sate to such a degree that the lineic absorbances as deter-
mined for partly purified haemoglobin solutions can be
applied. All methods hitherto used for clearing haemoly-
sates were top complicated and time-consuming and
could hardly be carried out without air-contact, a condi-
J.-Clin. Chem. Clin. Biochem. / VoL 19, 1981 / No. 7
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tion which is essential for the accurate measurement of
oxygen saturation. For the same reason any significant
degree of dilution of the blood with a reagent solution
had to be omitted. The small filter unit used in this
investigation offers only slight resistance to flow and
does not interfere with the filling of the cuvettes. Yet,
the ensuing haemoglobin solutions are clear enough for
the application of Lambert-Beer's law and the known
lineic absorbances. The method has not yet been tested
for blood with pathological plasma protein patterns. In
such cases, for the time being, it should be applied with
caution. The dilution of the sample with 5% Sterox SE
solution is so slight that even when the oxygen saturation
is near zero and the Sterox SE solution is in equilibrium
with air the ensuing change in oxygen saturation will be
less than 0.5%.
Wavelength and lightpath length are the most critical
factors for the validity of the five-wavelength method.
The wavelength scale of the spectrophotometer should
therefore be checked regularly. This is most easily done
with the aid of mercury emission lines. A small spectral
band width (< 1 nm) should be used and in each deter-
mination all wavelengths should be adjusted carefully.
The lightpath length of the cuvettes should be deter-
mined by comparative measurements with a calibrated
1 cm cuvette using various concentrations of a substance
exactly obeying Lambert-Beefs law. HiCN solutions
prepared in the same way as the International Reference
Solution (13) are suitable for this purpose. Checking the
absorbance scale with a filter of exactly known absorb-
ance is recommendable, though not strictly necessary
when a modern spectrophotometer is used.
Figures 3—6 show that the various haemoglobin deriva-
tives can be accurately determined by means of the five-
wavelength method. An objection which can be raised
against the applied testing procedure is that the test
samples usually contained only two haemoglobin deriva-
tives. This was a consequence of the fact that the
methods used for comparison, except for the determina-
tion of Hi, could only be applied to two-component sys-
tems. However, it should be noted that the five-wave-
length method correctly indicated zero concentration
for the components not present in the sample, which
certainly is indicative of the validity of the method.
As shown in figure 5, the comparative measurements of
Hi have been limited to the 0-30% range. We were
forced to do so, because the KCN addition method
progressively overestimates the Hi concentrations of
samples containing > 30% Hi. Some additional dilution
experiments indicated that the five-wavelength method
gives correct values for the Hi fraction at least up to
80%. The comparative measurements of SHb had to be
limited to the 0-25% range, because test samples with
more than 25% SHb can hardly be obtained with the
used. In spite of these limitations, the results
shown in figures 5 and 6 for Hi and SHb, respectively,
amply cover the clinically relevant range.
It may be regarded as a distinct advantage of the five-
wavelength method that it allows the simultaneous deter-
mination of Hi and SHb, which is of special interest in
toxicological cases. Although the KCN addition method
has originally been introduced as part of a determination
of Hi and SHb in a single sample of blood (17), it has
recently been shown that the presence of SHb results
in an appreciable overestimation of the Hi fraction by
this method (7).
If no other haemoglobin derivatives are present, the sum
of the concentrations as determined by the five-wave-
length method should be equal to c#b. This is beauti-
fully borne out by the data of figure 7: the regression
line is indistinguishable from the line of identity. These
results could be obtained in spite of the fact that the
reagent solution used in the HiCN method converts SHb
into SHiCN instead of into HiCN. However, the error
thus introduced is but slight (7). The fact that c^b (five-
wavelength) equals cnb (HiCN) offers an easy opportunity
for applying interparametric quality control (12). It will
be sound practice to supplement each determination of
haemoglobin derivatives by means of the five-wavelength
method with a determination of ofa (HiCN).
As shown in figure 1 and table 1 the set of wavelengths
chosen for the five-wavelength method contains for each
haemoglobin derivative a local maximum. The use of
ë = 760 nm for Hb at first sight seems rather curious,
ë = 555 nm being, the obvious choice. In fact we did try
to use ë = 555 nm instead of ë = 760 nm. This also has
the advantage that a spectrophotometer without a red-
sensitive photo-tube can be used. However, less accurate
results were obtained when the 555 nm maximum of Hb
was used. This was especially so in the determination of
the Hb02 and HbCO fractions. A possible explanation
for this might be the rather small differences between
6Hb, eHbO2 afld ^Hoco at ë = 555 and 569 nm. How-
ever, the experiments clearly demonstrate that
ë = 760 nm is to be preferred as the wavelength for
measurements.
Appendix
10 ! The file-name is 5 lambda
20 OPTION BASE 1
30 DIM Len (5), Abs (5), Con (5), Eps (5,5)
40 MAT READ Eps, Un
50 DATA 4.09, 5.05, 5.35, 9.04, 7.2
60 DATA 11.27,11.27,14.27,4.1, 8.1
70 DATA 9.4,15.37,10.0,4.1,8.1
80 DATA 1.23, .24, .33, 3.35, 20.8
90 DATA .43, .13, .03, .24, 1.04
100 DATA .0071, .0071, .0071, .2013, .2013 ! Own calibrated
values
110 FOR 1=1 to 5
120 F O R J = l t o 5
130 Eps (I, J) = Eps (I, J) * Len (I)
140 NEXTJ
150 NEXT I
160 MATEps = INV(Eps)
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170 PRINT 'The absorbances please"
180 MATINPUTAbs
190 MAT Con = Eps * Abs
200 Sum = SUM (Con) * Df ! Dilution-factor of syringe filled
with Sterox SE
210 PRINT USO2 % = "; 100 * Con (2)1 (Con (1) + Con (2))
220 PRINT "HbCO % = "; 100 * Con (3) / SUM (Con)
230 PRINT "Hi % = "; 100 * Con (4) / SUM (Con)
240 PRINT "SHb % = "; 100 * Con (5) / SUM (Con)
250 PRINT "C * Hb (g/dl) = "; Sum * 1.61145
260 END
References
1. Van Kämpen, E. J. & Zijlstra, W. G. (1965), in Advances in
Clinical Chemistry (Sobotka, H. & Stewart, C. P., eds.) Vol. 8,
141-187, Academic Press, New York/London.
2. Mook, G. A., Buursma, A., Gerding, A., Kwant, G. & Zijlstra,
W. G. (1979), Cardiovasc. Res. 13, 233-237.
3. Zijlstra, W. G. & Muller, C. J. (1957), Clin. Chim. Acta 2,
237-245.
4. Small, K. A., Radford, E. P., Frazier, J. M., Rodkey, F. L. &
Collison, H. A. (1971), J. Appl. Physiol. 31, 154-160.
5. Rodkey, F. L., Hill, . ., Pitts, L. L. & Robertson, R. F.
(1979), Clin. Chem. 25,1388-1393.
6. Siggaard-Andersen, O., Ntfrgaard-Pedersen, B. & Rem, J.
(1972), Clin. Chim. Acta«, 85-100.
7. Dijkhuizen, P., Buursma, A., Gerding, A. M. & Zijlstra, W. G.
(1977), Clin. Chim. Acta 78, 479-487.
8. Van Assendelft, O. W. (1970), Spectrophotometry of Haemo-
globin Derivatives, Van Gorcum and Comp., Assen, The
Netherlands.
9. Van Assendelft, O. W. & Zijlstra, W. G. (1975), Anal. Bio-
chem. 69, 43-48.
10. Van Kämpen, E. J. & Zijlstra, W. G. (1961), Clin. Chim.
Acta 6, 538-544.
11. International Committee for Standardization in Haematology
(1978), J. Clin. Pathol. 31, 139-143.
12. Van Kämpen, E. J. (1978), in New Pathways in Laboratory
Medicine (Rosalki, S. B., ed.), 132-140, Hans Huber
Publishers, Bern/Stuttgart/Vienna.
13. Zijlstra, W. G. & Van Kämpen, E. J. (1962), Clin. Chim.
Acta 7, 96-99.
14. Oeseburg, B. (1979), Crit. Care Med. 7, 396-398.
15. Mook, G. A., Van Assendelft, O. W. & Zijlstra, W. G. (1969),
Clin. Chim. Acta 26, 170-173.
16. Dijkhuizen, P., Buursma, A., Gerding, A. M., Van Kämpen,
E. J. & Zijlstra, W. G. (1977), Clin. Chim. Acta 80, 95-104.
17. Evelyn, K. A. & Malloy, H. T. (1938), J. Biol. Chem. 126,
655-662.
Prof. dr. W. G. Zijlstra
Department of Physiology
University of Groningen
Bloemsingel 10
NL-9712 KZ Groningen
The Netherlands
J. Clin. Chem. Clin. Biochem. / VoL 19,1981 / No. 7
ill

